Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of LINC02454-related key pathways and genes in papillary thyroid cancer by weighted gene coexpression network analysis (WGCNA). | Thyroid Res | 2024 | 39218967 | PubTator, text mining | PubMed |
| Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. | Biomolecules | 2024 | 39199357 | PubTator, text mining | PubMed |
| Machine learning and 4D-LFQ quantitative proteomic analysis explore the molecular mechanism of kidney stone formation. | Heliyon | 2024 | 39114033 | PubTator, text mining | PubMed |
| Oriented cellulose hydrogel: Directed tissue regeneration for reducing corneal leukoplakia and managing fungal corneal ulcers. | Bioact Mater | 2024 | 39101028 | PubTator, text mining | PubMed |
| Identifying the key hub genes linked with lung squamous cell carcinoma by examining the differentially expressed and survival genes. | Mol Genet Genomics | 2024 | 39097557 | PubTator, text mining | PubMed |
| Metastasis and basement membrane-related signature enhances hepatocellular carcinoma prognosis and diagnosis by integrating single-cell RNA sequencing analysis and immune microenvironment assessment. | J Transl Med | 2024 | 39085893 | PubTator, text mining | PubMed |
| A novel basement membrane-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma. | Front Oncol | 2024 | 39070142 | PubTator, text mining | PubMed |
| Identification and validation of basement membrane-related genes predicting prognosis and immune infiltration associated with bladder cancer. | Medicine (Baltimore) | 2024 | 39029072 | PubTator, text mining | PubMed |
| [Clinical and bioinformatics analysis of the relationship between LAMA3 DNA methylation expression and platinum resistance and prognosis in epithelial ovarian cancer]. | Zhonghua Fu Chan Ke Za Zhi | 2024 | 38951081 | PubTator, text mining | PubMed |
| Effects of nanomodified titanium surfaces considering bacterial colonization and viability of osteoblasts and fibroblasts. | J Biomed Mater Res A | 2024 | 38925622 | PubTator, text mining | PubMed |
| Novel role of NCoR1 in impairing spatial memory through the mediation of a novel interacting protein DEC2. | Cell Mol Life Sci | 2024 | 38900294 | PubTator, text mining | PubMed |
| Minimal Change Disease: Pathogenetic Insights from Glomerular Proteomics. | Int J Mol Sci | 2024 | 38891801 | PubTator, text mining | PubMed |
| Identification of established and novel extracellular matrix components in glioblastoma as targets for angiogenesis and prognosis. | Neurogenetics | 2024 | 38775886 | PubTator, text mining | PubMed |
| Early-stage lung cancer is driven by a transitional cell state dependent on a KRAS-ITGA3-SRC axis. | EMBO J | 2024 | 38755258 | PubTator, text mining | PubMed |
| Retraction Note: ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis. | Funct Integr Genomics | 2024 | 38730051 | PubTator, text mining | PubMed |
| Targeting Integrin α3 Blocks β1 Maturation, Triggers Endoplasmic Reticulum Stress, and Sensitizes Glioblastoma Cells to TRAIL-Mediated Apoptosis. | Cells | 2024 | 38727288 | PubTator, text mining | PubMed |
| MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3. | BMC Cancer | 2024 | 38702644 | PubTator, text mining | PubMed |
| Landscape of transcriptome-wide m6A modification in diabetic liver reveals rewiring of PI3K-Akt signaling after physical exercise. | Acta Physiol (Oxf) | 2024 | 38682314 | PubTator, text mining | PubMed |
| Downregulation of ABLIM3 confers to the metastasis of neuroblastoma via regulating the cell adhesion molecules pathway. | Comput Struct Biotechnol J | 2024 | 38645433 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment. | Clin Transl Med | 2024 | 38426403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=8